ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 22 filers reported holding ENVVENO MEDICAL CORPORATION in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $143,374 | +116.5% | 26,600 | +23.7% | 0.00% | – |
| Q2 2023 | $66,220 | -34.9% | 21,500 | 0.0% | 0.00% | – |
| Q1 2023 | $101,695 | -53.6% | 21,500 | -50.0% | 0.00% | – |
| Q4 2022 | $219,300 | +62.4% | 43,000 | +100.0% | 0.00% | – |
| Q3 2022 | $135,000 | +66.7% | 21,500 | 0.0% | 0.00% | – |
| Q2 2022 | $81,000 | -40.9% | 21,500 | 0.0% | 0.00% | – |
| Q1 2022 | $137,000 | +0.7% | 21,500 | +3.9% | 0.00% | – |
| Q4 2021 | $136,000 | – | 20,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 781,615 | $4,212,905 | 0.14% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 219,180 | $1,181,380 | 0.14% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 226,308 | $1,219,800 | 0.03% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 14,000 | $75,460 | 0.02% |
| Tamar Securities, LLC | 13,990 | $75,407 | 0.02% |
| Fermata Advisors, LLC | 11,850 | $63,873 | 0.02% |
| DIMENSIONAL FUND ADVISORS LP | 18,309 | $98,685 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,063 | $11,120 | 0.00% |
| NORTHERN TRUST CORP | 17,074 | $92,029 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |